Swedish Leisure Stock News

OM:CAMX
OM:CAMXPharmaceuticals

Why Camurus (OM:CAMX) Is Down 24.8% After Lifting 2026 Guidance and Showcasing Oxyesa Progress

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...
OM:ASKER
OM:ASKERHealthcare

European Stocks Possibly Priced Below Intrinsic Value In February 2026

As the European market experiences a wave of optimism, with the STOXX Europe 600 Index reaching new highs and major indexes like Germany’s DAX and France’s CAC 40 posting gains, investors are keenly observing opportunities amid this positive sentiment. In such an environment, identifying stocks that may be priced below their intrinsic value becomes crucial for those looking to capitalize on potential market inefficiencies.